Cookie use on MRCVSonline
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive all cookies.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Scientists develop novel bovine TB vaccine
The vaccine is the first to be compatible with a synthetic version of the tuberculin skin test.

Vaccine compatible with synthetic PPD skin test 

Researchers at the University of Surrey have produced a novel vaccine and complementary skin test to protect cattle against bovine Tb (bTB).

The vaccine, reported in the journal Scientific Reports, is the first to be compatible with a synthetic version of the tuberculin skin test (PPD), a test that is legally required in the UK for the surveillance of TB in cattle.

Researchers say the discovery could allow farmers and veterinary surgeons to protect their animals with the new BCG vaccine, while still maintaining a diagnostic test that will detect TB.

“In order to control the spread of bovine TB, effective vaccination and accurate early diagnosis of the disease are critical,” said Johnjoe McFadden, Professor of Molecular Genetics at the University of Surrey.
“This new vaccine provides protection against bovine TB and will help in the fight against this deadly disease which infects over 50 million cattle worldwide and is economically devastating to farmers.”

The BCG vaccine is currently used to protect humans and is effective in cattle. However, it is incompatible with the PPD skin test.
Cattle that receive the BCG vaccine - which contains a harmless strain of Mycobacterium bovis - produce a positive PPD test that makes it impossible to tell if the animal has TB or has been vaccinated against the disease.

It is for this reason that the BCG vaccine is banned in most countries, meaning vets continue to use the PPD skin test to diagnose the disease in cattle.

In this latest study, researchers set out to create a new strain of the BCG vaccine that lacks some of the proteins shared with Mycobacterium bovis. They did this by injecting cows with BCG strains that had each lost a single gene and measured the survival rates.

By employing this method, the researchers were able to identify genes that could be removed from BCG, without compromising its ability to work as a live vaccine.

The team deleted the dispensable genes from the BCG chromosome to make a BCG-minus strain. The deleted proteins were then used to develop a new synthetic skin test that would be positive for animals exposed to TB, but negative for animals vaccinated against the BCG-minus strain.

Subsequent tests of the synthetic PPD test on guinea pigs revealed that those infected with TB tested positive for the disease. Guinea pigs vaccinated with the BCG-minus vaccine, however, did not.

“The next stage of our work will be to demonstrate that both synthetic skin test and BCG-minus vaccine works in cattle herds,” professor McFadden continued. “If they do, then it will be possible to vaccinate cattle against TB yet retain the value of skin test for diagnosis.”

Become a member or log in to add this story to your CPD history

Big Butterfly Count returns

News Story 1
 The world's biggest survey of butterflies is back for 2020!

Butterfly Conservation's Big Butterfly Count launches on Friday, 17 July and will run until Sunday 9 August. Members of the public can get involved by downloading the Big Butterfly Count App or recording results on a downloadable sheet available from bigbutterflycount.org/.

'It's a fantastic activity for people from three to 103 years and we'd encourage everyone to take 15 minutes in an appropriate outdoor space during sunny conditions to simply appreciate the nature around them and do their bit to help us understand butterfly populations,' said a Butterfly Conservation spokesperson. 

Click here for more...
News Shorts
WellVet reopens ticket sales to online conference platform

Following the success of its online conference, the organisers behind WellVet Weekend have re-opened ticket sales to allow new delegates to access session recordings and its online networking platform.

The day-long conference saw more than 360 veterinary professionals mix activity sessions with personal development CPD, all hosted within a virtual conference platform. Now, with more than 500 minutes of CPD available, the resource is being re-opened to allow full access to the session recordings until May 2021.

Sessions are aimed at providing delegates with a range of proactive wellbeing tools to explore to find ways of improving their mental and physical health. Tickets are limited in number and on sale at wellvet.co.uk until 30th August 2020.